Pentoxifylline Extended-Release Tablets 400mg

Pentoxifylline Extended-Release Tablets 400mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

1. Pentoxifylline Extended-Release Tablets USP 400mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

1. Pentoxifylline Extended-Release Tablets USP 400mg
Each extended-release film coated tablet contains:
Pentoxifylline USP……………………400mg
Excipients…………………………………. q.s.
Colours: Erythrosine

THERAPEUTIC INDICATIONS:

Pentoxifylline can be used to treat:
1. Peripheral vascular disease (poor circulation to the arms and legs).
2. Intermittent claudication (pain on walking or at rest caused by poor circulation to the legs).

CAUTION &  WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH

WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A registered medical practitioner.

STORAGE & DOSAGE:

Storage: Store below 30°C.
Protect from Light.

Dosage: As directed by the Physician.

Introduction to Pentoxifylline Extended-Release Tablets 400mg

Pentoxifylline Extended-Release Tablets 400mg are a prescription medication widely used in the treatment of intermittent claudication—leg pain, cramping, or weakness caused by reduced blood flow due to chronic peripheral arterial disease (PAD). The drug works by improving blood circulation and reducing blood viscosity, enabling better oxygen delivery to tissues, especially in the arms and legs.

Globally, peripheral vascular diseases are rising due to aging populations, diabetes, smoking, and sedentary lifestyles. This has created consistent demand for proven circulation-improving medicines. As a result, Pentoxifylline Extended-Release Tablets 400mg manufacturers in India have become key suppliers to international healthcare markets due to India’s cost efficiency, quality manufacturing, and regulatory compliance.

Taj Pharma, the well-known Pentoxifylline Extended-Release Tablets 400mg Manufacturer in India, gives strong assurance of high quality and purity. The company is trusted by global buyers for its regulatory-ready products, ethical manufacturing practices, and reliable export capabilities.

  Trusted Manufacturer, Exporter & Supplier from Vapi, Gujarat

Taj Pharma Ltd. India is a well-established Manufacturer, Exporter, and Supplier of Pentoxifylline Extended-Release Tablets 400mg from Vapi, Gujarat, India—one of the country’s leading pharmaceutical manufacturing hubs.

Pentoxifylline Extended-Release Tablets 400mg are used in the treatment of:

• Peripheral vascular disease

• Intermittent claudication

• Circulatory disorders affecting hands and feet

Taj Pharma ensures that every tablet meets international quality standards, making it suitable for PAN India distribution and global exports.

Mechanism of Action & Clinical Benefits

Pentoxifylline is classified as a peripheral vasodilator. It works by:

• Decreasing blood viscosity (thickness)

• Improving red blood cell flexibility

• Enhancing microcirculation

These effects help blood flow more easily through narrowed blood vessels, particularly in patients with peripheral arterial disease. This leads to reduced leg pain, improved walking distance, and better quality of life.

Dosage, Administration & Patient Guidance

• Take Pentoxifylline Extended-Release Tablets 400mg exactly as prescribed by your doctor

• Consume with food, preferably at the same time every day

• Do not crush or chew the extended-release tablet

Patients are advised not to drive or operate machinery until they understand how the medication affects them. Doctors may recommend regular blood tests to monitor liver function during treatment.

Pregnant or breastfeeding women, or those planning pregnancy, should inform their physician before starting therapy.

In-Depth Details for Importers, Exporters & Buyers

Regulatory Documentation Provided

Taj Pharma offers comprehensive regulatory support, including:

• WHO-GMP Certificate

• Certificate of Pharmaceutical Product (COPP)

• Free Sale Certificate (FSC)

• Manufacturing License

• Certificate of Analysis (COA)

• Stability Study Data

• Batch Manufacturing Records (BMR)

• CTD / eCTD Dossiers (Modules 1–5, on request)

Custom Packaging & Labeling

• Alu-Alu blister packs

• PVC blister or strip packs

• Bottles for institutional supply

• Buyer-specific artwork and branding

• Multilingual labeling as per importing country regulations

• Serialization and barcoding support

Shelf-Life, Storage & Dosage Form

• Dosage Form: Extended-release tablet

• Strength: 400mg

• Shelf Life: 36 months

• Storage: Store below 25°C, protected from light and moisture

Export Certifications

• WHO-GMP

• ISO 9001:2015

• COPP

• CTD Dossier support

• EU-GMP (through partner facilities, if required)

Target Countries & Export Markets

Taj Pharma exports Pentoxifylline Extended-Release Tablets 400mg from India to:

• Africa

• Southeast Asia

• Middle East

• CIS countries

• Latin America

Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

State-of-the-Art Manufacturing

• WHO-GMP compliant production facilities in Vapi

• Automated tablet compression and coating lines

• Controlled extended-release formulation technology

• Strict in-process and finished product testing

Affordable Pricing & Quality Assurance

• Competitive export pricing

• Consistent batch-to-batch quality

• Robust QA/QC systems

• Compliance with international pharmacopeial standards

Global Presence & Supply Chain Support

• Reliable international logistics partners

• Timely deliveries across continents

• Regulatory and registration assistance

• Long-term supply agreements for bulk buyers

Top 20 Countries Taj Pharma Exports To

India , Bangladesh, Nepal, Sri Lanka, Vietnam, Philippines, Cambodia, Nigeria, Kenya, Ghana, Egypt, Ethiopia, Morocco, Peru, Colombia, Ecuador, Bolivia , Ukraine, Uzbekistan, Kazakhstan

Technical Product Specification 

PAN India & Mumbai Supply Leadership

Taj Pharma is a PAN India Manufacturer and Supplier of Pentoxifylline Extended-Release Tablets 400mg, with strong market presence in:

• Mumbai, Maharashtra

• Gujarat

• Delhi NCR

• Hyderabad

• Chennai

The company is recognized as a Leading  Pentoxifylline Extended-Release Tablets 400mg Manufacturer & Supplier in India and also offers PCD Pharma Franchise opportunities with monopoly rights and promotional support.

Call to Action 

If you are looking for a dependable Pentoxifylline Extended-Release Tablets 400mg Manufacturer Supplier in India, Taj Pharma is your ideal partner. From regulatory documentation to global logistics, Taj Pharma delivers excellence at every stage.

👉 Contact Taj Pharma today for export inquiries, pricing, dossiers, samples, or PCD Pharma Franchise opportunities.

Top 20 FAQs  

1. What is Pentoxifylline Extended-Release Tablets 400mg used for?
   It treats intermittent claudication caused by peripheral arterial disease.

2. Is Taj Pharma WHO-GMP certified?
   Yes, Taj Pharma is WHO-GMP certified.

3. Can this product be exported from India?
   Yes, with full regulatory documentation.

4. What is the shelf life?
   36 months.

5. Does Taj Pharma provide COPP?
   Yes.

6. Are CTD dossiers available?
   Yes, on request.

7. What packaging options are offered?
   Blister, Alu-Alu, and bottles.

8. Is it safe during pregnancy?
   Use only after consulting a doctor.

9. Should it be taken with food?
   Yes, preferably with food.

10. Does it cause drowsiness?
    It may in some patients.

11. Is extended-release formulation important?
    Yes, it ensures sustained therapeutic levels.

12. Is PAN India supply available?
    Yes.

13. Is Mumbai supply available?
    Yes.

14. Does Taj Pharma offer PCD franchise?
    Yes.

15. Which countries does Taj Pharma export to?
    Over 20 countries worldwide.

16. Does it improve blood circulation?
    Yes, by reducing blood viscosity.

17. Can tablets be crushed?
    No, extended-release tablets should not be crushed.

18. What storage conditions are required?
    Below 25°C, dry place.

19. Is bulk supply available?
    Yes.

20. How to contact Taj Pharma?
    Via official website or export inquiry channels.